Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.


Last reviewed on RxList: 3/8/2021
Soriatane Side Effects Center

What Is Soriatane?

Soriatane (acitretin) is a retinoid, which is a form of vitamin A, used to treat severe psoriasis in adults. Soriatane is usually given after other psoriasis medicines have been unsuccessful. Soriatane is not a cure for psoriasis, and you may relapse after you stop taking this medication.

What Are Side Effects of Soriatane?

Common side effects of Soriatane include:

  • redness
  • itching
  • skin scaling
  • peeling
  • dry skin
  • sticky feeling on the skin the first several weeks as your body adjusts to the medication

 Other side effects of Soriatane include:

  • dry eyes
  • eye irritation
  • crusting of the eye lids
  • chapped or peeling skin
  • increased sensitivity to sunlight
  • dry mouth
  • peeling of the skin of fingertips/palms/soles of feet
  • weak nails
  • fragile skin
  • chapped lips
  • dry or runny nose
  • nosebleeds
  • thirst
  • taste changes
  • hair loss
  • headache
  • muscle tightness
  • nausea
  • stomach pain
  • diarrhea
  • flushing (warmth, redness, or tingly feeling)
  • sleep problems (insomnia)
  • ringing in your ears

What Are Side Effects of Soriatane?

Dosage for Soriatane

The starting dose of Soriatane is a single dose of 25 to 50 mg per day, with a meal. Maintenance doses of 25 to 50 mg per day may be given.

What Drugs, Substances, or Supplements Interact with Soriatane?

Soriatane may interact with phenytoin or St. John's wort. Other drugs may interact with Soriatane. Tell your doctor all prescription and over-the-counter medications and supplements you use.

Soriatane During Pregnancy and Breastfeeding

Soriatane must not be used during pregnancy. This drug should not be used if you are planning to become pregnant during treatment or within 3 years after use has stopped. Use 2 forms of birth control starting 1 month before and during treatment and at least 3 years after use has stopped. Semen may pose a risk to a pregnant woman if a male is using this drug. Consult your doctor. It is unknown if this drug is excreted into breast milk. Breastfeeding is not recommended while using this medication and for at least three years after the medication has been stopped.

Additional Information

Our Soriatane (acitretin) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Types of Psoriasis: Medical Pictures and Treatments See Slideshow
Soriatane Consumer Information

3 pharmacies near 20147 have coupons for Soriatane (Brand Names:Soriatane for 10MG)

Safeway Pharmacy
Safeway Pharmacy

Est. Regular Price


with free coupon

View Coupon
CVS Pharmacy
CVS Pharmacy

Est. Regular Price


with free coupon

View Coupon
Walmart Pharmacy
Walmart Pharmacy

Est. Regular Price


with free coupon

View Coupon

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using acitretin and call your doctor at once if you have:

  • mood changes--depression, aggression, unusual thoughts or behavior, thoughts of hurting yourself;
  • heart attack or stroke symptoms--chest pain, dizziness, nausea, feeling short of breath, sudden numbness or weakness (especially on one side of the body), sudden severe headache, problems with speech or balance, swelling or warmth in one or both legs;
  • high blood sugar--increased thirst, increased urination, dry mouth, fruity breath odor, headache, blurred vision;
  • increased pressure inside the skull--severe headaches, ringing in your ears, dizziness, nausea, vision problems, pain behind your eyes;
  • liver problems--nausea, vomiting, loss of appetite, dark urine, or jaundice (yellowing of your skin or eyes);
  • problems with your bones or muscles--loss of feeling in your hands or feet, trouble moving, pain in your back, joints, muscles, or bones;
  • serious skin problems--itching, redness, pain, swelling or peeling of your skin; or
  • signs of a blood vessel problem--sudden swelling, rapid weight gain, fever, muscle pain, feeling light-headed.

Common side effects may include:

  • chapped lips, dry mouth;
  • itchy or scaly skin;
  • weak nails, fragile skin;
  • peeling skin on your hands and feet;
  • hair loss;
  • dry eyes, discomfort while wearing contact lenses;
  • dry or runny nose, nosebleeds; or
  • joint pain, tight muscles.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Soriatane (Acitretin)


Psoriasis causes the top layer of skin cells to become inflamed and grow too quickly and flake off. See Answer
Soriatane Professional Information


Hypervitaminosis A produces a wide spectrum of signs and symptoms primarily of the mucocutaneous, musculoskeletal, hepatic, neuropsychiatric, and central nervous systems. Many of the clinical adverse reactions reported to date with administration of SORIATANE resemble those of the hypervitaminosis A syndrome.

Adverse Events/Postmarketing Reports

In addition to the events listed in the tables for the clinical trials, the following adverse events have been identified during postapproval use of SORIATANE. Because these events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Cardiovascular: Acute myocardial infarction, thromboembolism (see WARNINGS), stroke.

Immune System Disorders: Hypersensitivity, including angioedema and urticaria (see CONTRAINDICATIONS).

Nervous System: Myopathy with peripheral neuropathy has been reported during therapy with SORIATANE. Both conditions improved with discontinuation of the drug.

Psychiatric: Aggressive feelings and/or suicidal thoughts have been reported. These events, including self-injurious behavior, have been reported in patients taking other systemically administered retinoids, as well as in patients taking SORIATANE. Since other factors may have contributed to these events, it is not known if they are related to SORIATANE (see PRECAUTIONS).

Reproductive: Vulvo-vaginitis due to Candida albicans.

Skin and Appendages: Thinning of the skin, skin fragility, and scaling may occur all over the body, particularly on the palms and soles; nail fragility is frequently observed. Madarosis and exfoliative dermatitis/erythroderma have been reported (see WARNINGS).

Vascular Disorders: Capillary leak syndrome (see WARNINGS).

Clinical Trials

During clinical trials with SORIATANE, 513 of 525 (98%) subjects reported a total of 3,545 adverse events. One-hundred sixteen subjects (22%) left trials prematurely, primarily because of adverse experiences involving the mucous membranes and skin. Three subjects died. Two of the deaths were not drug-related (pancreatic adenocarcinoma and lung cancer); the other subject died of an acute myocardial infarction, considered remotely related to drug therapy. In clinical trials, SORIATANE was associated with elevations in liver function test results or triglyceride levels and hepatitis.

The tables below list by body system and frequency the adverse events reported during clinical trials of 525 subjects with psoriasis.

Table 3. Adverse Events Frequently Reported during Clinical Trials Percent of Subjects Reporting (N = 525)

Body System >75% 50% to 75% 25% to 50% 10% to 25%
CNS       Rigors
Eye Disorders       Xerophthalmia
Mucous Membranes Cheilitis   Rhinitis Dry mouth
Musculoskeletal       Arthralgia
Spinal hyperostosis (progression of existing lesions)
Skin and Appendages   Alopecia Skin peeling Dry skin Nail disorder
Erythematous rash
Skin atrophy
Sticky skin

Table 4. Adverse Events Less Frequently Reported during Clinical Trials (Some of Which May Bear No Relationship to Therapy) Percent of Subjects Reporting (N = 525)

Body System 1% to 10% <1%
Body as a Whole Anorexia
Hot flashes
Increased appetite
  Alcohol intolerance
Influenza-like symptoms
Muscle weakness
Weight increase
Cardiovascular Flushing   Chest pain
Increased bleeding time
Intermittent claudication
Peripheral ischemia
CNS (also see Psychiatric) Headache Pain   Abnormal gait
Migraine Neuritis
Pseudotumor cerebri (intracranial hypertension)
Eye Disorders Abnormal/ blurred vision
Conjunctivitis/ irritation
Corneal epithelial abnormality
Decreased night vision/night blindness
Eye abnormality
Eye pain
Abnormal lacrimation
Conjunctival hemorrhage
Corneal ulceration
Itchy eyes and lids
Recurrent sties
Subepithelial corneal lesions
Gastrointestinal Abdominal pain
Tongue disorder
Tongue ulceration
Liver and Biliary     Hepatic function abnormal
Gingival bleeding
Gingivitis Increased saliva
Ulcerative stomatitis
Altered saliva
Anal disorder
Gum hyperplasia
Musculoskeletal Arthritis
Back pain
Peripheral joint hyperostosis (progression of existing lesions)
Bone disorder
Olecranon bursitis
Spinal hyperostosis (new lesions)
Psychiatric Depression
Libido decreased
Reproductive     Atrophic vaginitis
Respiratory Sinusitis   Coughing
Increased sputum
Skin and Appendages Abnormal skin odor
Abnormal hair texture
Bullous eruption
Cold/clammy skin
Increased sweating
Psoriasiform rash
Pyogenic granuloma
Skin fissures
Skin ulceration
Breast pain
Fungal infection
Hair discoloration
Herpes simplex
Impaired healing
Otitis media
Otitis externa
Photosensitivity reaction
Psoriasis aggravated
Skin nodule
Skin hypertrophy
Skin disorder
Skin irritation
Sweat gland disorder
Special Senses/ Other Earache
Taste perversion
Taste loss
Urinary     Abnormal urine
Penis disorder


Therapy with SORIATANE induces changes in liver function tests in a significant number of patients. Elevations of AST (SGOT), ALT (SGPT) or LDH were experienced by approximately 1 in 3 subjects treated with SORIATANE. In most subjects, elevations were slight to moderate and returned to normal either during continuation of therapy or after cessation of treatment. In subjects receiving SORIATANE during clinical trials, 66% and 33% experienced elevation in triglycerides and cholesterol, respectively. Decreased high density lipoproteins (HDL) occurred in 40% (see WARNINGS). Transient, usually reversible elevations of alkaline phosphatase have been observed.

Table 5 lists the laboratory abnormalities reported during clinical trials.

Table 5. Abnormal Laboratory Test Results Reported during Clinical Trials Percent of Subjects Reporting

Body System 50% to 75% 25% to 50% 10% to 25% 1% to 10%
Electrolytes     Increased: Increased and decreased:
  • Magnesium
  • Phosphorus
  • Potassium
  • Sodium
Increased and decreased:
  • Calcium
  • Chloride
Hematologic   Increased:
  • Reticulocytes
Decreased: Increased:
  • Haptoglobin
  • Neutrophils
  • WBC
  • Bands
  • Basophils
  • Eosinophils
  • Hematocrit
  • Hemoglobin
  • Lymphocytes
  • Monocytes
  • Haptoglobin
  • Lymphocytes
  • Neutrophils
  • Reticulocytes
Increased or decreased:
  • Platelets
  • RBC
Hepatic   Increased:
  • Cholesterol
  • LDH
  • SGOT
  • SGPT
  • Alkaline phosphatase
  • Direct bilirubin
  • GGTP
  • Globulin
  • Total bilirubin
  • Total protein
Increased and decreased:
Miscellaneous Increased:
  • Triglycerides
  • CPK
  • Fasting blood sugar
  • Fasting blood sugar
  • High occult blood
Increased and decreased:
  • Iron
Renal     Increased: Increased:
  • BUN
  • Creatinine
Urinary   WBC in urine Acetonuria Hematuria RBC in urine Glycosuria Proteinuria

Read the entire FDA prescribing information for Soriatane (Acitretin)

Related Resources for Soriatane

Related Health

Read the Soriatane User Reviews »

© Soriatane Patient Information is supplied by Cerner Multum, Inc. and Soriatane Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.


Types of Psoriasis: Medical Pictures and Treatments See Slideshow

Health Solutions From Our Sponsors